BioCentury
ARTICLE | Clinical News

Cancidas caspofungin acetate regulatory update

August 11, 2008 7:00 AM UTC

FDA approved an sNDA from Merck to expand the label for Cancidas caspofungin to include the treatment of indicated fungal infections in pediatric patients aged 3 months to 17 years. The inhibitor of b...